SALE

mpMRI prostate

Name: mpMRI Prostate | BNH Hospital
SKU: MB_96741-2
Price: 19900 THB
Availability: InStock

Original price was: ฿23,000.Current price is: ฿19,900.

Multiparametric MRI, or mpMRI, is a specialised MRI exam built specifically to image the prostate gland — layering several MRI techniques together to build a far more complete picture than a standard scan.

“Multiparametric” simply means many parameters. A conventional MRI shows anatomy — the shape and size of the gland. mpMRI adds two more layers: how densely packed the tissue is at a cellular level, and how the tissue’s blood supply behaves. Cancerous tissue tends to behave differently across all three measures, which is what makes it visible.

The scan is read and scored by a radiologist using PI-RADS, a standardised international scale, so the result means the same thing regardless of where it’s read. mpMRI has become a standard step in prostate cancer evaluation, most often used before a first biopsy or to monitor a prostate already under surveillance.

It is a diagnostic tool, not a treatment. Its job is to answer: is there anything in the gland that looks suspicious, exactly where does it sit, and how urgently should it be investigated further.

Description

The Package includes:

Creatinine test
Urologist’s initial consultation fee
Radiologist’s fee
Contrast media
Medical supplies during the procedure
Hospital’s service fee

Terms and Conditions

Appointments should be booked at least 3–5 business days in advance to secure MRI scanner availability and a consultation slot. Please make an appointment via BNH Cares at LINE @BNHhospital or contact our staff for assistance at LINE @mcentrebybnh
A referral letter is not required to book, but bringing prior PSA results or imaging helps the radiologist compare findings.
Packages are booked under the named patient and are non-transferable to another individual.
Services are available at the M Centre, Surgery Department, 1st floor, zone A, BNH Hospital. Monday – Sunday at 7 am. – 7 pm.
For more information, please contact the Surgery Department, BNH Hospital at 02-022-0721 or our Hotline at: +66 63 445 7854, Monday – Sunday at 7 am. – 7 pm.

Preparing for your scan

Preparation is minimal. A few small steps beforehand meaningfully improve image quality, and recovery afterward is immediate for almost everyone.

Avoid ejaculation for 3 days beforehand to reduce swelling that can obscure the scan. Eat lightly the day before if advised. Continue your regular medications unless told otherwise, and tell the coordinator about any metal implants, pacemaker, or contrast allergy when you book.

During the scan

You’ll change into a gown, then lie on your back on the scanner table for about 30–45 minutes. The scanner is loud but not painful — you’ll hear knocking and buzzing sounds. A small IV line delivers contrast partway through for the DCE sequence.

Post Care

There’s no sedation involved, so you can drive, eat, and return to normal activity immediately. Drink some extra water over the next day to help clear the contrast agent. The IV site may be mildly tender for a few hours — this is normal.

What happens next?

Day 0: Scan completed
Images are sent to radiology for interpretation the same day.

3–5 days: Report ready
A radiologist finalizes your report and PI-RADS score. Most results are ready within 3 to 5 working days; complex cases may take slightly longer.

Follow-up visit: Results consultation
Your included follow-up appointment covers what the score means for you specifically, alongside your PSA and history.

Your report is graded on the PI-RADS scale (1 to 5), describing how likely a finding is to represent clinically significant cancer.

If the scan is clear (PI-RADS 1–2)

Clinically significant cancer is unlikely. Your urologist will typically recommend continued routine monitoring — such as periodic PSA testing — rather than a biopsy.

If something suspicious is found (PI-RADS 3–5):

Your urologist will discuss a targeted biopsy of the flagged area, using the mpMRI images to guide exactly where to sample — often via MRI-fusion biopsy. A PI-RADS 3 may sometimes call for closer monitoring first rather than immediate biopsy, depending on your PSA and history.

Who is mpMRI Prostate for?

1. Individuals with an elevated or rising PSA

Before a first biopsy, to decide whether one is warranted and, if so, where to sample.

2. Individuals are on active surveillance:

Men already diagnosed with low-risk prostate cancer, monitoring for change instead of immediate treatment.

3. Individuals with abnormal finding on digital rectal exam

A firm or irregular area found on examination that needs further characterisation.

4. Individuals with prior negative biopsy, ongoing concern:

When PSA remains a concern despite an earlier clear biopsy result.

5. Individuals planning treatment

Mapping the extent of a known cancer before surgery, radiotherapy, or focal therapy.

6. Individuals with family history or risk factors

Men with a stronger inherited risk profile, wanting a closer baseline look with their doctor.

Frequently Asked Questions (FAQ) about mpMRI prostate

Q: How accurate is mpMRI at catching prostate cancer?

A: mpMRI is very good at not missing dangerous prostate cancer, but it isn’t a standalone diagnosis. In the landmark PROMIS trial, mpMRI correctly identified 93% of clinically significant cancers, compared with 48% for standard ultrasound-guided biopsy. Independent meta-analyses since then put its typical sensitivity in the 74–88% range, depending on the patient group studied. The trade-off is specificity: mpMRI also flags some areas that turn out not to be cancer, which is why any suspicious result is still followed up with a targeted biopsy rather than treated as a final diagnosis.

Source: Ahmed et al., “PROMIS” trial, The Lancet, 2017 (DOI: 10.1016/S0140-6736(16)32401-1); pooled meta-analyses, AJR & Academic Radiology

Q: What's the actual difference between mpMRI and a regular prostate MRI?

A: A standard MRI shows the structure of the prostate — its size, shape, and general appearance — much like a detailed photograph of the gland.

An mpMRI (multiparametric MRI) goes further by adding two additional types of information to that same image:

Tissue density: This sequence shows how closely packed the cells are in a given area. Cancer cells tend to grow more densely than healthy tissue, so this can help highlight areas worth a closer look.
Blood flow: This sequence tracks how blood moves through the prostate. Tumors often develop their own blood supply to support their growth, which can appear as a distinct pattern on the scan.

By combining these three views — structure, cell density, and blood flow — mpMRI gives your doctor a more complete picture of the prostate than a standard MRI alone, which is why it’s now the preferred scan for prostate cancer evaluation.

Source: European Society of Urogenital Radiology, PI-RADS v2.1 guidance on mpMRI sequences

Q: Is the contrast injection used during the scan safe?

A: For most people, yes. The gadolinium-based contrast used for the blood-flow (DCE) portion of the scan is a routine part of the exam, and significant reactions are uncommon. Patients with significant kidney impairment or a known contrast allergy are screened out beforehand at the pre-scan consultation.

Source: American College of Radiology, ACR Manual on Contrast Media

Q: Will the health insurance cover mpMRI for Prostate?

A: Many international plans cover diagnostic imaging for suspected cancer, but coverage varies by policy. BNH’s international patient team can help verify your coverage and provide an itemized estimate before you commit to travel or treatment.